Boehringer Ingelheim is working on groundbreaking treatments that improve the lives of humans and animals. As a leading research-driven pharmaceutical company, we create value through innovation. Not more of the same, but precisely in those areas where the need is greatest. Such as diabetes, lung disease and cardiovascular disease. Boehringer Ingelheim - founded in 1885 - is still a family business with a long-term perspective.